This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignee: Invox Pharma Limited. Active years: 2024-2026.
Company Filing History:
Years Active: 2024-2026
Title: Sarka Pechouckova: Innovator in Cancer Treatment
Introduction
Sarka Pechouckova is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biomedical research, particularly in the development of innovative therapies for cancer and infectious diseases. With a total of 2 patents to his name, Pechouckova is recognized for his groundbreaking work in antibody technology.
Latest Patents
One of Sarka Pechouckova's latest patents is titled "ANTI-CD137 ANTIBODIES - Fc binding fragments comprising a CD137 antigen-binding site." This invention relates to specific binding members that target CD137, a protein involved in immune responses. The specific binding members include a CD137 antigen-binding site located in a constant domain, which has potential applications in treating various cancers and infectious diseases.
Career Highlights
Sarka Pechouckova is currently associated with Invox Pharma Limited, where he continues to advance his research and development efforts. His work is pivotal in the ongoing quest for effective treatments that can improve patient outcomes in oncology and immunology.
Collaborations
Throughout his career, Pechouckova has collaborated with esteemed colleagues, including Matthew Lakins and Jose Munoz-Olaya. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapeutic solutions.
Conclusion
Sarka Pechouckova stands out as a key figure in the field of biomedical innovation, with a focus on antibody therapies that hold promise for treating serious health conditions. His contributions are shaping the future of medical treatments and improving the lives of many patients.